1. Firestein GS. Etiology and pathogenesis of rheumatoid arthritis.2 th ed. Sunders Publication. 2001;P. 921-66.

2. Koopman WJ. Moreland LW. Arthritis and allied conditions a textbook of rheumatology. 1 th ed. Lip Williams Wilkins Publication.2005;P.213-26.

3. Davatchi F. Pattern of rheumatic diseases in Asia pacific and the tropics. Ann Sci Meet Am Coll Rheumatol2005;2;201-9. doi.10.4103/0019-5359.103160

4. Klippel J, Dieppe P, Arnett F. Rheumatology. 2th ed. London Mosby Publication.1998;P.311-29.

5. Isenberg DA. Oxford textbook of rheumatology.1 th ed. Oxford Uni London Publication. 2004; P.172-8. doi. 10.1093/rheumatology/kem108

6. Imboden JB, Hellmann DB, Stone JH. Current rheumatology diagnosis and treatment. Curr Rheumatol Diagnos Treat 2007;3: 123-9.

7. West SG. Rheumatology secrets.1th ed. Else Health Sci Publication.2002:

8. Anderson D. Harrisons principles of internal medicine. Neurology2005;64: 1488-9.

9. Hastings DE, Evans JA. Rheumatoid wrist deformities and their relation to ulnar drift. J Bone Join SurgAm 1975;57: 930-4.

10. Akbariean M, Salehiabri E.Rheumatoid disease. 1th ed. Tehran Uni Publication. 2005;1:81-9.

11. Prevoo M. Modified disease activity scores that include twenty eight‐joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arth Rheum Off J Am Coll Rheumatol1995;38: 44-8.doi.10.1002/art.1780380107

12. Felson DT. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arth Rheum Off J Am1993;36:729-40. doi.10.1002/art. 1780360601

13. Agresti A. A model for repeated measurements of a multivariate binary response. J Am Sta As1997;92: 315-21.doi. 10.1080/01621459.1997.10473629

14. Conaghan PG. Persistently moderate DAS-28 is not benign: loss of function occurs in early RA despite step-up DMARD therapy. Rheumatology 2010;49: 1894-9. doi.10.1093/rheumatology/keq178

15. Heagerty PJ. Marginally specified logistic normal models for longitudinal binary data. Biometrics 1999; 55: 688-98. doi.10.1111/j.0006-341x.1999.00688.x

16. Heagerty PJ, Zeger SL. Marginalized multilevel models and likelihood inference with comments and a rejoinder by the authors. Sta Sc 2000; 15: 1-26.

17. 17 YacoubY, Amine B, Laatiris A, Hajjajhassouni N. Health related quality of life in Moroccan patients with rheumatoid arthritis. Clin Rheumatol2012; 31: 1471-7. doi.10.1007/s10067-012-2037-x

18. Paco MJ, Welsingrobert B, Landewe M, Piet LCM, Riel V. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis a longitudinal analysis. Arth Rheum Offi J Am Coll Rheumatol2004; 50: 2082-93. doi.10.1002/art.20350

19. Praevoo M. Modified disease activity scores that include twenty eight joint counts. Arth Rheum 1995;38: 44-8. doi.10.1002/art.1780380107.

20. Saddamhussain MS, Tripathi V. Smoking under hypoxic conditions a potent environmental risk factor for inflammatory and autoimmune diseases. Militar Med Res 2018. 5: 1-14. doi.10.1186/s40779-018-0158-5

21. Uhlig T, Hagen K, Kvien T. Current tobacco smoking formal education and the risk of rheumatoid arthritis. J Rheumatol1999; 26: 47-54.doi.10.1136/ard. 59.8.631

22. Cranney ANN, Horsley T, Odonnell S, Weiler H, Puil L, Ooi D, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol As2007; 1:22-7.

23. Mawer EB, Davies M. Vitamin D nutrition and bone disease in adults. Rev Endocr Metab Dis2001;2: 153-64.doi.10.1023/A:1010002710485

24. Esalatmanesh. [The relationship between serum vitamin d level and patient activity in patients with rheumatoid arthritis]. Feyz J Kashan Uni Med Sci 2011;14: 414-9. (Persian) doi.10.7860/JCDR/ 2017/24014. 9486

25. Turhanoglu AD. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int2011;31: 911-4. doi.10.1007/s00296-010-1393-6

26. Craig SM. Vitamin D status and its associations with disease activity and severity in African Americans with recent onset rheumatoid arthritis. J Rheumatol 2010. 37: 275-81.doi.10.3899/jrheum.090705

27. Oelzner P. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tis Int1998. 62: 193-8. doi.310.1007/s002239900416

28. Wolfe F, Hawley D. The longterm outcomes of rheumatoid arthritis. Work. J Rheumatol 1998; 25: 2107-8. doi.10.1136/ard.2003.011395

29. Moghimi N. [Relationship between platelet indices and severity of rheumatoid arthritis according to DAS28 criteria]. Sci J Kurdistan Uni Med Sci 2014;19: 1-8. (Persian)

30. Mobedi Z. [The effect of oral royal jelly on clinical disease activity index and morning stiffness in patients with rheumatoid arthritis a randomized double blind placebo controlled trial]. J Isfahan Med Sch 2013; 31: 1428-34. (Persian)